No Data
No Data
AstraZeneca Announces Share Capital and Voting Rights
Why AstraZeneca PLC (AZN) Is One of the Most Profitable Pharmaceutical Stocks Right Now?
The Zacks Analyst Blog Highlights Roche, Poseida Therapeutics, Merck, AstraZeneca and Novartis
USA Stock Market Outlook | Three major equity index futures rise together, US retailers prepare for Black Friday, the market will close 3 hours early on Friday.
On November 29 (Friday) during pre-market trading, all three major equity index futures in the U.S. rose.
Astrazeneca (AZN.US) Class 1 new drug approved for clinical trials in China for the first time, aiming to develop treatment for heart failure.
Astrazeneca (AZN.US) has received an implied license for clinical trials of its Class 1 new drug AZD5462 in china, which is intended for the treatment of heart failure.
AstraZeneca Partner's Orpathys Secures Renewal on China's Drug Reimbursement List
loading...